STOCK TITAN

[Form 4] NewtekOne, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

On July 1, 2025, Director Richard J. Salute filed a Form 4 reporting that on June 30, 2025 he received 2,283 restricted shares of NewtekOne, Inc. (NEWT) common stock under the shareholder-approved 2023 Stock Incentive Plan. The award is coded “A” (grant) at an indicated price of $10.95 per share and will vest 100 % after 12 months. Any dividends declared during the restricted period will be paid in additional common shares that follow the same vesting schedule. After this grant, Salute’s direct beneficial ownership increases to 41,505 shares. No derivative securities or open-market transactions were disclosed, and the filing was submitted solely by the reporting person.

Il 1° luglio 2025, il Direttore Richard J. Salute ha presentato un Modulo 4 segnalando che il 30 giugno 2025 ha ricevuto 2.283 azioni vincolate di azioni ordinarie di NewtekOne, Inc. (NEWT) nell'ambito del Piano di Incentivi Azionari 2023 approvato dagli azionisti. L'assegnazione è classificata come “A” (concessione) a un prezzo indicativo di 10,95 $ per azione e maturerà al 100% dopo 12 mesi. Eventuali dividendi dichiarati durante il periodo di vincolo saranno corrisposti in azioni ordinarie aggiuntive che seguiranno lo stesso calendario di maturazione. Dopo questa concessione, la posizione diretta di proprietà effettiva di Salute aumenta a 41.505 azioni. Non sono stati divulgati titoli derivati né transazioni sul mercato aperto, e la comunicazione è stata presentata esclusivamente dalla persona segnalante.

El 1 de julio de 2025, el Director Richard J. Salute presentó un Formulario 4 informando que el 30 de junio de 2025 recibió 2,283 acciones restringidas de acciones ordinarias de NewtekOne, Inc. (NEWT) bajo el Plan de Incentivos de Acciones 2023 aprobado por los accionistas. La adjudicación está codificada como “A” (concesión) a un precio indicado de $10.95 por acción y se consolidará al 100% después de 12 meses. Cualquier dividendo declarado durante el período restringido se pagará en acciones ordinarias adicionales que seguirán el mismo calendario de consolidación. Después de esta concesión, la propiedad directa beneficiaria de Salute aumenta a 41,505 acciones. No se divulgaron valores derivados ni transacciones en el mercado abierto, y la presentación fue realizada únicamente por la persona que reporta.

2025년 7월 1일, 이사 리처드 J. 살루테는 제출서식 4를 통해 2025년 6월 30일에 주주 승인 2023년 주식 인센티브 계획에 따라 NewtekOne, Inc.(NEWT) 보통주 2,283주의 제한 주식을 받았음을 보고했습니다. 이 수여는 “A”(부여)로 분류되며 주당 10.95달러의 지정 가격으로, 12개월 후 100% 완전 취득됩니다. 제한 기간 동안 선언된 배당금은 동일한 취득 일정에 따라 추가 보통주로 지급됩니다. 이번 수여 후 살루테의 직접 실질 소유 주식 수는 41,505주로 증가합니다. 파생 증권이나 공개 시장 거래는 공개되지 않았으며, 보고는 해당 인물에 의해 단독으로 제출되었습니다.

Le 1er juillet 2025, le Directeur Richard J. Salute a déposé un formulaire 4 indiquant que le 30 juin 2025, il a reçu 2 283 actions restreintes d’actions ordinaires de NewtekOne, Inc. (NEWT) dans le cadre du Plan d’Incitation à l’Actionnariat 2023 approuvé par les actionnaires. L’attribution est codée « A » (attribution) à un prix indiqué de 10,95 $ par action et acquiert 100 % de droits après 12 mois. Tout dividende déclaré pendant la période de restriction sera payé en actions ordinaires supplémentaires suivant le même calendrier d’acquisition. Après cette attribution, la possession directe bénéficiaire de Salute augmente à 41 505 actions. Aucun titre dérivé ni transaction sur le marché ouvert n’ont été divulgués, et le dépôt a été effectué uniquement par la personne déclarante.

Am 1. Juli 2025 reichte Direktor Richard J. Salute ein Formular 4 ein und berichtete, dass er am 30. Juni 2025 2.283 eingeschränkte Aktien der Stammaktien von NewtekOne, Inc. (NEWT) im Rahmen des von den Aktionären genehmigten Aktienanreizplans 2023 erhalten hat. Die Zuteilung ist als „A“ (Gewährung) codiert zu einem angegebenen Preis von 10,95 $ pro Aktie und wird nach 12 Monaten zu 100 % unverfallbar sein. Während der Sperrfrist erklärte Dividenden werden in zusätzlichen Stammaktien ausgezahlt, die dem gleichen Unverfallbarkeitsplan folgen. Nach dieser Zuteilung erhöht sich Salutes direkter wirtschaftlicher Eigentumsanteil auf 41.505 Aktien. Es wurden keine derivativen Wertpapiere oder Transaktionen am offenen Markt offengelegt, und die Meldung wurde ausschließlich von der meldenden Person eingereicht.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine incentive grant; aligns director’s interests but immaterial to share count or control.

The filing reflects a standard board-approved equity incentive. 2,283 shares represent a modest addition to Mr. Salute’s 41,505-share holding and do not alter governance dynamics or control thresholds. Full one-year vesting is consistent with typical retention plans. Because the grant stems from the existing 2023 Stock Incentive Plan, shareholder authorization is already in place, limiting dilution concerns. Overall governance impact is neutral.

TL;DR: Insider awarded ≈$25k in stock; negligible to valuation, neutral trading signal.

The director did not deploy personal capital; instead, shares were granted by the company. At the referenced $10.95 price, the award value is roughly $25 k—immaterial versus daily trading volume and outstanding shares. With no accompanying purchase or sale, the filing offers limited insight into management’s market view. I see no immediate portfolio implications.

Il 1° luglio 2025, il Direttore Richard J. Salute ha presentato un Modulo 4 segnalando che il 30 giugno 2025 ha ricevuto 2.283 azioni vincolate di azioni ordinarie di NewtekOne, Inc. (NEWT) nell'ambito del Piano di Incentivi Azionari 2023 approvato dagli azionisti. L'assegnazione è classificata come “A” (concessione) a un prezzo indicativo di 10,95 $ per azione e maturerà al 100% dopo 12 mesi. Eventuali dividendi dichiarati durante il periodo di vincolo saranno corrisposti in azioni ordinarie aggiuntive che seguiranno lo stesso calendario di maturazione. Dopo questa concessione, la posizione diretta di proprietà effettiva di Salute aumenta a 41.505 azioni. Non sono stati divulgati titoli derivati né transazioni sul mercato aperto, e la comunicazione è stata presentata esclusivamente dalla persona segnalante.

El 1 de julio de 2025, el Director Richard J. Salute presentó un Formulario 4 informando que el 30 de junio de 2025 recibió 2,283 acciones restringidas de acciones ordinarias de NewtekOne, Inc. (NEWT) bajo el Plan de Incentivos de Acciones 2023 aprobado por los accionistas. La adjudicación está codificada como “A” (concesión) a un precio indicado de $10.95 por acción y se consolidará al 100% después de 12 meses. Cualquier dividendo declarado durante el período restringido se pagará en acciones ordinarias adicionales que seguirán el mismo calendario de consolidación. Después de esta concesión, la propiedad directa beneficiaria de Salute aumenta a 41,505 acciones. No se divulgaron valores derivados ni transacciones en el mercado abierto, y la presentación fue realizada únicamente por la persona que reporta.

2025년 7월 1일, 이사 리처드 J. 살루테는 제출서식 4를 통해 2025년 6월 30일에 주주 승인 2023년 주식 인센티브 계획에 따라 NewtekOne, Inc.(NEWT) 보통주 2,283주의 제한 주식을 받았음을 보고했습니다. 이 수여는 “A”(부여)로 분류되며 주당 10.95달러의 지정 가격으로, 12개월 후 100% 완전 취득됩니다. 제한 기간 동안 선언된 배당금은 동일한 취득 일정에 따라 추가 보통주로 지급됩니다. 이번 수여 후 살루테의 직접 실질 소유 주식 수는 41,505주로 증가합니다. 파생 증권이나 공개 시장 거래는 공개되지 않았으며, 보고는 해당 인물에 의해 단독으로 제출되었습니다.

Le 1er juillet 2025, le Directeur Richard J. Salute a déposé un formulaire 4 indiquant que le 30 juin 2025, il a reçu 2 283 actions restreintes d’actions ordinaires de NewtekOne, Inc. (NEWT) dans le cadre du Plan d’Incitation à l’Actionnariat 2023 approuvé par les actionnaires. L’attribution est codée « A » (attribution) à un prix indiqué de 10,95 $ par action et acquiert 100 % de droits après 12 mois. Tout dividende déclaré pendant la période de restriction sera payé en actions ordinaires supplémentaires suivant le même calendrier d’acquisition. Après cette attribution, la possession directe bénéficiaire de Salute augmente à 41 505 actions. Aucun titre dérivé ni transaction sur le marché ouvert n’ont été divulgués, et le dépôt a été effectué uniquement par la personne déclarante.

Am 1. Juli 2025 reichte Direktor Richard J. Salute ein Formular 4 ein und berichtete, dass er am 30. Juni 2025 2.283 eingeschränkte Aktien der Stammaktien von NewtekOne, Inc. (NEWT) im Rahmen des von den Aktionären genehmigten Aktienanreizplans 2023 erhalten hat. Die Zuteilung ist als „A“ (Gewährung) codiert zu einem angegebenen Preis von 10,95 $ pro Aktie und wird nach 12 Monaten zu 100 % unverfallbar sein. Während der Sperrfrist erklärte Dividenden werden in zusätzlichen Stammaktien ausgezahlt, die dem gleichen Unverfallbarkeitsplan folgen. Nach dieser Zuteilung erhöht sich Salutes direkter wirtschaftlicher Eigentumsanteil auf 41.505 Aktien. Es wurden keine derivativen Wertpapiere oder Transaktionen am offenen Markt offengelegt, und die Meldung wurde ausschließlich von der meldenden Person eingereicht.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
SALUTE RICHARD J

(Last) (First) (Middle)
4800 T-REX AVENUE
SUITE 120

(Street)
BOCA RATON FL 33431

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
NewtekOne, Inc. [ NEWT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/30/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common stock 06/30/2025 A(1) 2,283 A $10.95 41,505 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. On June 30, 2025, under the Shareholder and Board approved NewtekOne, Inc. 2023 Stock Incentive Plan, the reporting person was granted 2,283 restricted shares of the Issuer's common stock as a restricted stock award with 100% of the shares vesting after 12 months. Dividends in the form of common stock will be paid during the restricted period, and such common stock will also vest pursuant to the vesting schedule.
Remarks:
Richard Salute 07/01/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many shares did Director Richard J. Salute receive in the latest insider filing for NEWT?

2,283 restricted shares were granted on June 30, 2025.

When will the newly granted NEWT shares vest?

The award vests 100 % after 12 months from the June 30, 2025 grant date.

What is Richard J. Salute’s total beneficial ownership in NewtekOne after the transaction?

He now directly owns 41,505 common shares of NEWT.

Was the insider transaction an open-market buy or a stock grant?

It was a stock grant (Transaction Code “A”) under the 2023 Stock Incentive Plan.

Will dividends be paid on the restricted NEWT shares during the vesting period?

Yes, dividends will be paid in common stock and will vest on the same 12-month schedule.
NewtekOne, Inc.

NASDAQ:NEWT

NEWT Rankings

NEWT Latest News

NEWT Latest SEC Filings

NEWT Stock Data

294.50M
24.48M
6.99%
36.43%
5.44%
Banks - Regional
National Commercial Banks
Link
United States
BOCA RATON